Advanced

Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease.

Lundblad, Martin LU ; Andersson, Malin LU ; Winkler, Christian LU ; Kirik, Deniz LU ; Wierup, Nils LU and Cenci Nilsson, Angela LU (2002) In European Journal of Neuroscience 15(1). p.120-132
Abstract
In an attempt to define clinically relevant models of akinesia and dyskinesia in 6-hydroxydopamine (6-OHDA)-lesioned rats, we have examined the effects of drugs with high (L-DOPA) vs. low (bromocriptine) dyskinesiogenic potential in Parkinson's disease on three types of motor performance, namely: (i) abnormal involuntary movements (AIMs) (ii) rotational behaviour, and (iii) spontaneous forelimb use (cylinder test). Rats with unilateral 6-OHDA lesions received single daily i.p. injections of L-DOPA or bromocriptine at therapeutic doses. During 3 weeks of treatment, L-DOPA but not bromocriptine induced increasingly severe AIMs affecting the limb, trunk and orofacial region. Rotational behaviour was induced to a much higher extent by... (More)
In an attempt to define clinically relevant models of akinesia and dyskinesia in 6-hydroxydopamine (6-OHDA)-lesioned rats, we have examined the effects of drugs with high (L-DOPA) vs. low (bromocriptine) dyskinesiogenic potential in Parkinson's disease on three types of motor performance, namely: (i) abnormal involuntary movements (AIMs) (ii) rotational behaviour, and (iii) spontaneous forelimb use (cylinder test). Rats with unilateral 6-OHDA lesions received single daily i.p. injections of L-DOPA or bromocriptine at therapeutic doses. During 3 weeks of treatment, L-DOPA but not bromocriptine induced increasingly severe AIMs affecting the limb, trunk and orofacial region. Rotational behaviour was induced to a much higher extent by bromocriptine than L-DOPA. In the cylinder test, the two drugs initially improved the performance of the parkinsonian limb to a similar extent. However, L-DOPA-treated animals showed declining levels of performance in this test because the drug-induced AIMs interfered with physiological limb use, and gradually replaced all normal motor activities. L-DOPA-induced axial, limb and orolingual AIM scores were significantly reduced by the acute administration of compounds that have antidyskinetic efficacy in parkinsonian patients and/or nonhuman primates (-91%, yohimbine 10 mg/kg; -19%, naloxone 4-8 mg/kg; -37%, 5-methoxy 5-N,N-dimethyl-tryptamine 2 mg/kg; -30%, clozapine 8 mg/kg; -50%, amantadine 40 mg/kg). L-DOPA-induced rotation was, however, not affected. The present results demonstrate that 6-OHDA-lesioned rats do exhibit motor deficits that share essential functional similarities with parkinsonian akinesia or dyskinesia. Such deficits can be quantified using novel and relatively simple testing procedures, whereas rotometry cannot discriminate between dyskinetic and antiakinetic effects of antiparkinsonian treatments. (Less)
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
Female, Gait : drug effects, Levodopa : pharmacology, Motor Activity : drug effects, Oxidopamine : pharmacology, Parkinson Disease Secondary : chemically induced : psychology, Rats, Rats Sprague-Dawley, Rotation, Stereotyped Behavior : drug effects, Sympatholytics : pharmacology, Support Non-U.S. Gov't, Dyskinesia Drug-Induced : drug therapy : psychology, Bromocriptine : pharmacology, Behavior Animal : drug effects, Antiparkinson Agents : pharmacology, Anti-Dyskinesia Agents : pharmacology, Animal
in
European Journal of Neuroscience
volume
15
issue
1
pages
120 - 132
publisher
Wiley-Blackwell
external identifiers
  • wos:000174057800013
  • pmid:11860512
  • scopus:0036459952
ISSN
1460-9568
DOI
10.1046/j.0953-816x.2001.01843.x
language
English
LU publication?
yes
id
fcedeb80-e108-44de-9885-f70f2082f778 (old id 106830)
date added to LUP
2007-07-17 11:07:36
date last changed
2017-12-10 03:46:43
@article{fcedeb80-e108-44de-9885-f70f2082f778,
  abstract     = {In an attempt to define clinically relevant models of akinesia and dyskinesia in 6-hydroxydopamine (6-OHDA)-lesioned rats, we have examined the effects of drugs with high (L-DOPA) vs. low (bromocriptine) dyskinesiogenic potential in Parkinson's disease on three types of motor performance, namely: (i) abnormal involuntary movements (AIMs) (ii) rotational behaviour, and (iii) spontaneous forelimb use (cylinder test). Rats with unilateral 6-OHDA lesions received single daily i.p. injections of L-DOPA or bromocriptine at therapeutic doses. During 3 weeks of treatment, L-DOPA but not bromocriptine induced increasingly severe AIMs affecting the limb, trunk and orofacial region. Rotational behaviour was induced to a much higher extent by bromocriptine than L-DOPA. In the cylinder test, the two drugs initially improved the performance of the parkinsonian limb to a similar extent. However, L-DOPA-treated animals showed declining levels of performance in this test because the drug-induced AIMs interfered with physiological limb use, and gradually replaced all normal motor activities. L-DOPA-induced axial, limb and orolingual AIM scores were significantly reduced by the acute administration of compounds that have antidyskinetic efficacy in parkinsonian patients and/or nonhuman primates (-91%, yohimbine 10 mg/kg; -19%, naloxone 4-8 mg/kg; -37%, 5-methoxy 5-N,N-dimethyl-tryptamine 2 mg/kg; -30%, clozapine 8 mg/kg; -50%, amantadine 40 mg/kg). L-DOPA-induced rotation was, however, not affected. The present results demonstrate that 6-OHDA-lesioned rats do exhibit motor deficits that share essential functional similarities with parkinsonian akinesia or dyskinesia. Such deficits can be quantified using novel and relatively simple testing procedures, whereas rotometry cannot discriminate between dyskinetic and antiakinetic effects of antiparkinsonian treatments.},
  author       = {Lundblad, Martin and Andersson, Malin and Winkler, Christian and Kirik, Deniz and Wierup, Nils and Cenci Nilsson, Angela},
  issn         = {1460-9568},
  keyword      = {Female,Gait : drug effects,Levodopa : pharmacology,Motor Activity : drug effects,Oxidopamine : pharmacology,Parkinson Disease Secondary : chemically induced : psychology,Rats,Rats Sprague-Dawley,Rotation,Stereotyped Behavior : drug effects,Sympatholytics : pharmacology,Support Non-U.S. Gov't,Dyskinesia Drug-Induced : drug therapy : psychology,Bromocriptine : pharmacology,Behavior Animal : drug effects,Antiparkinson Agents : pharmacology,Anti-Dyskinesia Agents : pharmacology,Animal},
  language     = {eng},
  number       = {1},
  pages        = {120--132},
  publisher    = {Wiley-Blackwell},
  series       = {European Journal of Neuroscience},
  title        = {Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease.},
  url          = {http://dx.doi.org/10.1046/j.0953-816x.2001.01843.x},
  volume       = {15},
  year         = {2002},
}